title: Etrolizumab: anti-β7-a novel therapy for ulcerative colitis.
authors.affiliation: Center for Colitis and Crohn's Disease, Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, California.
authors.forename: Kirk K
authors.initials: KK
authors.lastname: Lin
authors.affiliation: Center for Colitis and Crohn's Disease, Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, California.
authors.forename: Uma
authors.initials: U
authors.lastname: Mahadevan
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents